Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Insulet $419 million repurchases of convertible senior notes
We advised the agent on the transaction
Microchip Technology $1.485 billion convertible preferred stock offering
The company issued depositary shares each representing a 1/20th interest in a share of its convertible preferred stock
Falabella cash tender offer
We advised the company on the tender offer
Entergy $1.457 billion stock offering and forward sale agreements
The common stock is listed on the NYSE
Visen Pharmaceutical HK$783.3 million IPO
The shares are listed on the HKEX
Insulet $450 million senior notes offering
The high-yield notes are due 2033
Caixa Seguridade R$1.2 billion equity offering
The shares are listed on the São Paulo Stock Exchange
AMD $1.5 billion senior notes offering
The investment-grade notes are due 2026 and 2028
QXO $830 million private placement
The shares are traded on the NYSE
Integer Holdings $1 billion convertible senior notes offering
The 1.875% convertible senior notes are due 2030